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Dear Prof Crunelli 
 
Revision of manuscript JNEUMETH-D-16-00018 
 
Thank you for giving us the opportunity to revise our paper for your journal. We appreciate the 
constructive comments of the referees, please find below our response to their comments.  The 
changes made to the paper are indicated below and are marked in red in the manuscript. 
 
Response to Referee 1 
 
1. First, in figure 3, there are several regions that have been extracted in figure 3B and 3D that are 
not positive in the pre-extracted images.   
 
Also, the arrows in 3A don't match 3B and same for 3C and 3D. 
 
Also in these images, there is extra tissue around each cell removed by this methodology, 
however there is no scale bar or objective used for these images shown, so the "extra" regions 
around the cell cannot be quantified.  These images show that this method is not exact.   
 
We agree with the reviewer that this approach will not isolate a pure population, rather it 
will enable a significantly enriched fraction to be obtained.  We have amended the text to 
ensure that the limitation of this technique is highlighted.  We have also amended the 
figures as recommended by the reviewer to clearly label the xMD-ed cells. 
 
2. It would be good to quantify the amount of extra tissue extracted via this method compared to 
LCM using the caps provided by Life Technologies. 
 
While we acknowledge that this comparison would be of interest and enable the two 
current LCM approaches to be compared, as mentioned above we accept that using the 
*Revision Notes
 xMD approach will not isolate a pure population of cells.  By presenting the XMD approach 
in this manuscript it will provide an alternative approach for researchers. 
 
3. Figure 4 shows very poor Agilent results with rampant background and very low RIN, which while 
low RINs are expected from PPFE tissue, the high background does not accurately measure the 
RNA content.  
We are familiar with this problem from our LCM work with post mortem tissue. It appears to 
be a feature of the degraded RNA that one encounters in these preparations. We 
acknowledge that it does not accurately measure RNA content but enables us to compare 
sample quality. 
 
4. They also only show this for one sample and do not show it from the glial cells verses neurons.  It 
is very important with a new methodology to show more than one sample.  There should be a 
table or figure of all of the results using this methodology with before and after RINs. 
We agree with the reviewer and have now included additional examples of isolated glia, 
with RIN values before and after xMD, in Figure 4. 
 
5. The authors state that they use "Approximately 200 cells were collected RNA extraction was 
conducted with the following protocol." They do not quantify how much RNA they use for the 
reverse transcription step, which will be very different amounts of RNA starting RNA from neurons 
verses glial cells.  Qiagen estimates a yield of 10-30pg of total RNA per cell, with mRNA 
accounting for only 1-5% of that number. However, when doing the RT-PCR they state they use 
50ng of cDNA.  They do not state how the cDNA is measured.  Is this estimated from the RNA 
starting amounts?  There should be an Agilent DNA chip done on these samples to show the 
purity, amount and fragment size of the cDNA present. 
The estimation of RNA quantity is generated from the NanoDrop value. We acknowledge 
that this is inaccurate but we have found from previous work that when converted to cDNA 
or used in a microarray that we can use these values as a guide. We have not found that 
Agilent DNA chips for cDNA are particularly helpful in this regard. 
 
6. A negative control experiment showing that simply binding the film to the stained sections does 
not result in adhesion of the cells should be done and shown as well. 
A negative control, omitting the primary antibody, was included and demonstrated no 
specific immunoreactivity and no resulting cellular adhesion.  An example of the xMD 
negative controls is included in the appendix. 
 
 
Response to Referee 2 
 
1. To demonstrate advantages of xMD, authors selected the brain region where the cell density is 
relatively low as shown in Figure 3. How does this technique work if the regions with tightly 
packed cell bodies of the different cell types are studied? 
xMD in the white matter of the same tissue has been conducted with successful results, 
however, for demonstration purposes for the paper it was more appropriate to showcase 
the technique using the less densely populated cortical region. Other studies have used 
different tissues with higher cellular densities to obtain cells via xMD (Hanson et al. 2004, 
Tangrea et al. 2011).  This has now been highlighted in the discussion. 
 
2. As seen in Figure 3, xMD results in capturing excessive areas that surround the cells. Is it 
possible to reduce these excessive areas or adjust their size? 
While alternative films with different polymer densities could be used, currently adjusting 
laser pulse, duration and intensity will not reduce the size of the area activated by the 
action of the laser.  This is also a recognised limitation of the standard LCM approach. 
 
3. Authors showed that transcripts for GFAP were not detected in the targeted NeuN-positive cells. It 
is well known that not all astrocytes express gene encoding GFAP in healthy brain. To confirm 
purity of the neuronal population isolated by xMD, an analysis of expression of other astroglial 
genes such as genes encoding S100beta or GLAST/EAAT-1 is required. 
 We agree with the reviewer that not all astrocytes are GFAP+ and that a good pan-astrocyte 
marker is currently lacking.  However, not all astrocytes are EAAT1+ and S100B is not 
selective for astrocytes alone.  It is certainly an important consideration that users of this 
technique should be aware of, and we have now added this discussion to the text. 
 
4. Positive controls for CD68 and OLIG2 must be added.  To confirm the enrichment, real-time PCR 
analysis of xMD and non-xMD samples from the same region of the brain is required. This 
approach also provides positive controls for all tested genes and allows for the quantitative 
estimation of the enrichment. 
Positive controls of total extracts were included in each run, and have now been added to 
Figure 5. 
 
 
5. I cannot agree with the view that the exclusion of an operator from the process reduces non-
specific contamination. In contrast with this view, I believe that an operator may reduce non-
specific contamination. For instance, in the case when the automatic recognition of the cells of 
interest is used for common laser capture microdissection, an operator can control the recognition 
process and exclude objects that were recognized by mistake. Moreover, the accuracy of the cell 
isolation by laser capture microdissection may be supported by making images before and after 
the laser capture microdissection procedure. At the same time, it seems that xMD may be used for 
perfectly stained preparations. If some artifacts of the staining are present, inadequate isolation by 
xMD may occur. Give reasons for your view. 
We completely agree with the reviewer that high background staining and artefacts will 
interfere with the isolation of an enriched population, contributing to contamination of the 
extract.  It is imperative that time is spent optimising each antibody to ensure a specific 
pattern of immunoreactivity is obtained with minimal background staining.  We have 
amended the text accordingly. 
 
Minor concerns: 
The figure numbers mentioned in the text are mostly improper. Check the numeration of the figure 
references in the text. 
Scale bars are absent in Figures 2 and 3 in my version of the manuscript. 
Check spelling of 'Chromogen' through the text. 
Clarify Figure 4. Where is RNA integrity number before and after xMD? 
We thank the reviewer for making us aware of these errors and have amended the text 
accordingly. 
 
 
Response to Referee 3 
 
1. Data display²The authors have gene expression data regarding cell-specific captures for six rats.  
Rather than show an agarose gel, the authors should display the data quantitatively.  The gene 
expression data for GFAP, OLIG2, CD68, and Tub3 could have been easily shown as relative 
expression levels for the six samples in both cell types--provided the authors can quantify with a 
standard. 
While we agree with the reviewer that qPCR would have been an alternative approach, in 
the current study we were looking to achieve a semi-quantitative assessment of cellular 
enrichment and felt the standard PCR would demonstrate this adequately. 
 
2. Efficiency²200 hundred cells were collected, but 50 ng was used per PCR reaction for each gene.  
According to Figure 4, (possibly beyond sensitivity of Agilent) the author demonstrates 4-6 
nanograms per sample, likely per microliter (author did not indicate).  Elution was 20 microliters 
therefore the author could perform gene expression analysis for only 2 genes per RNA purification.  
Each capture may contain varying amounts of neuropil thus resulting in variable RNA amounts. 
As stated above in the response to Reviewer 1 the values for RNA concentration are only a 
guide that we use to help us in the preparation of the cDNA. We agree that not many genes 
can be assayed for expression levels but we have demonstrated previously that this is 
feasible from LCM captured material. 
 3. Lack of appropriate experimental controls²I feel confident that the authors performed a 
nonspecific secondary binding experiment, but failed to mention it in the written manuscript.  I find 
the ABC kit can allow nonspecific binding to frozen tissue, but may be less susceptible to 
nonspecific binding with FFPE tissue, but at least a mention of a negative control would have 
been a good practice to prove there is limited nonspecific gene expression. 
As mentioned above in the response to Reviewer 1, negative controls were included in the 
experiments.  Both omission of the primary antibody and an isotype control were included, 
neither of which gave any non-specific immunoreactivity.  We apologise for omitting this in 
the manuscript and have amended the text accordingly. 
 
4. Housekeeping gene/loading control²The authors did not mention whether a loading control or 
housekeeping gene (s) was used to standardize expression levels of the cell-specific marker 
genes.  The authors may have standardized to RNA amounts or number of cells, but the RNA 
quantity shown in the picochip in the samples in figure 4 appear to be above the level of sensitivity. 
The PCR was standardised using equivalent amounts of cDNA.   
 
Figures/technical aspects: 
5. Gene names should be italicized throughout manuscript, HUGO name should be used 
consistently. 
The text has been amended. 
 
6. Figure 1.  I would rather a rudimentary experiment (possible addition with this figure) that 
demonstrates the intensity of EVA/DAB binding can affect the number of cells captured i.e. a 
primary or secondary dilution curve demonstrating changes in the amounts of GFAP and TUB3 
expression. 
Each antibody was optimised and the conditions which produced the highest level of 
specific immunoreactivity with the lowest levels of background staining were selected from 
a range of antibody titrations. 
 
7. Combine Figure 2 and Figure 3. For completeness, the authors could have displayed a negative 
control in panel 1, immunohistochemical identification for NeuN or GFAP in panel 2, and captured 
area in panel 3 for one figure. 
An example of the negative control included in each experiment has been added as an 
appendix.  :KLOHZHDSSUHFLDWHWKH5HYLHZHU¶VVXJJHVWLRQWRFRPELQH)LJXUHVDQGZH
feel that they are more suited to being independent figures. 
 
8. Figure 4.  The authors exceed the sensitivity of the picochip (5000 picograms) leading to potential 
errors regarding RNA amount and RIN. 
We take the point that we are struggling with the estimation of RNA quality and have 
discussed this in the response to both previous reviewers. We continue to use the 
methodologies we are familiar with as a guide to our subsequent experimentation. We have 
investigated other measurement technologies but nothing has, yet, given us any better 
results.  
 
9. Figure 5.  No referral in manuscript, although I assume authors meant to indicate Figure 5 rather 
than Figure 4 on page 7. 
We apologise for this oversight and have amended the manuscript accordingly. 
 
 
Yours sincerely 
 
 
 
Paul Heath 
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Abstract  
Background: Laser capture microdissection (LCM) is an established technique for the 
procurement of enriched cell populations that can undergo further downstream analysis, 
although it does have limitations. Expression microdissection (xMD) is a new technique that 
begins to address these pitfalls, such as operator dependence and contamination. 
New Method: xMD utilises immunohistochemistry in conjunction with a chromoagen to 
isolate specific cell types by extending the fundamental principles of LCM to create an 
operator-independent method for the procurement of specific CNS cell types.  
Results: We report how xMD enables the isolation of specific cell populations, namely 
neurones and astrocytes, from rat formalin fixed-paraffin embedded (FFPE) tissue. 
Subsequent reverse transcriptase-polymerase chain reaction (RT-PCR) analysis confirms 
the enrichment of these specific populations. RIN values after xMD indicate samples are 
sufficient to carry out further analysis. 
Comparison with existing method: xMD offers a rapid method of isolating specific CNS 
cell types without the need for identification by an operator, reducing the amount of 
unintentional contamination caused by operator error, whilst also significantly reducing the 
time required by the current basic LCM technique.  
Conclusions: xMD is a superior method for the procurement of enriched cell populations 
from post-mortem tissue, which can be utilised to create transcriptome profiles, aiding our 
understanding of the contribution of these cells to a range of neurological diseases. xMD 
also addresses the issues associated with LCM, such as reliance on an operator to identify 
target cells, which can cause contamination, as well as addressing the time consuming 
nature of LCM. 
 
 
Abbreviations: 
CNS; central nervous system, LCM; laser capture microdissection, EVA; ethylene vinyl 
DFHWDWH'$%¶-diaminobenzidine, xMD; expression microdissection, FFPE; formalin fixed 
paraffin embedded, RT-PCR; reverse transcriptase polymerase chain reaction, ABC; 
avidin/biotinylated complex, DEPC; diethylpyrocarbonate, TBS; Tris-buffered saline, UV; 
ultra violet, RIN; RNA integrity number. 
Keywords:  
Expression microdissection; Laser capture microdissection; Neurones; Astrocytes; RNA; 
RNA integrity number   
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1. Introduction 
It has long been recognised that in order to unravel the underlying pathologies of 
central nervous system (CNS) disorders, it is necessary to identify the contributions of 
individual cell types to the overall disease process. We previously reported an immuno-LCM 
technique that combines rapid immunostaining with standard laser capture microdissection 
(LCM) to enable the isolation of an enriched population of cells from frozen post-mortem 
tissue [15]. Using this approach, we have carried out a number of studies to enrich for 
populations of specific CNS individual cell types to compare the gene expression profile of 
disease and non-disease cells, including oligodendrocytes [1], astrocytes [3] and neurones 
[8, 11]. This approach has been useful in identifying disease-relevant gene expression 
related changes which can then be investigated further, but the protocols are somewhat 
lengthy and it can, on occasion, be difficult to confidently identify certain cells.  
The development of the expression microdissection (xMD) technique [12], later 
refined  [7], offers a new approach to streamline and simplify the isolation of specific cell 
populations, removing the need for a microscope or cell identification by the user, making it 
an operator independent process. Similar to the LCM preparation process, for xMD, tissue 
sections undergo Immunohistochemistry for a cell-type-specific antigen. Tissue sections are 
then covered with an ethylene vinyl acetate (EVA) polymer film and the whole tissue is 
irradiated with a low energy infra-red laser. When the laser is fired over an immunopositive 
cell, the EVA film melts, causing a thermoplastic bond to occur between the EVA film and 
the immunopositive cell, adhering the cell to the EVA film. The film can then be removed 
from the tissue, taking with it only the immunopositive cells that have formed a thermoplastic 
bond with the EVA polymer, after which they can then be placed in extraction buffer for 
further downstream analysis (Figure 1). 
In the current study, formalin-fixed paraffin embedded (FFPE) post-mortem tissue 
was used to highlight how this resource can be used in conjunction with the expression 
microdissection technique to acquire enriched central nervous system (CNS) cell 
populations, namely neurones and astrocytes. For the purpose of this proof of principle study 
the neurone marker NeuN and a widely used astrocyte marker GFAP were the antibodies of 
choice. Histopathologically well-characterised archival FFPE tissue is currently an 
underutilised resource that has the potential to unravel underlying mechanisms contributing 
to disease pathogenesis. To date, two studies have been conducted utilising this method as 
a means to isolate specific cell types [4, 6]. However, neither of these studies isolated CNS 
cells, making the method described here novel for these specific cell types.  
This paper describes the detailed methodology of xMD which can be used to isolate 
enriched populations of specific cell types from FFPE tissue, and confirms this enrichment 
by RT-PCR.  Future studies can potentially use this technique in well characterised archived 
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FFPE cohorts to investigate the contribution of specific cell types to the pathogenesis of a 
range of neurological diseases. 
 
2. Materials and Methods 
2.1 Rat brain tissue 
Formalin fixed paraffin embedded (FFPE) post mortem rat brain tissue blocks were 
obtained from 6 Sprague Dawley adult rats. Cell isolation was carried out from the 
hippocampal region.  
 
2.2 Immunohistochemistry  
5µm sections were collected onto sterile charged slides. Sections were dewaxed in 
xylene and rehydrated to DEPC-water in a graded series of alcohols (100%, 100%, 95%, 
70% EtOH for 5 min each).  Immunohistochemistry was used following the standard 
avidin/biotinylated enzyme complex (ABC) staining method (Vector Laboratories, UK). All 
work was carried out at room temperature (RT) under RNase-free conditions. Sections were 
blocked in 1.5% relevant normal serum for 30 min, then incubated in the appropriate specific 
antibody (glial fibrillary acidic protein [Dako catalogue number Z0334] 1:500; NeuN 
[Chemicon catalogue number MAB377] 1:100) diluted in blocking serum for 1 hour before 
washing with Tris-buffered saline (TBS) for 5 min. Sections were then incubated with 0.5% 
biotinylated secondary antibody for 30 min, washed with TBS for 5 min, and then incubated 
with 2% horse-radish peroxidise conjugated ABC for 30 min and washed with TBS for 5 min. 
$QWLERG\VWDLQLQJZDVYLVXDOLVHGZLWK¶-diaminobenzidine (DAB) as chromogen (Vector 
Laboratories, UK) for 3 min. Sections were rinsed in DEPC-water and dehydrated in graded 
alcohols (70%, 95%, 100%, 100% for 15 s each) then cleared in xylene for 5 mins. Sections 
were left to air dry in an air flow hood for approximately one hour prior to baking. Each 
antibody was optimised in order to ensure a specific pattern of immunoreactivity was 
achieved with minimal background staining. The optimisation process included the 
appropriate negative controls with primary antibody exclusion and an isotype control to 
ensure there was no non-specific reactivity.   
 
2.3 Film and slide preparation for microdissection 
CoTran 19% ethylene-vinyl acetate (EVA) film (3M, cat. No. 3M CoTran 9715) was 
sterilised in an ultraviolet (UV) air flow hood for 20 min. Using a sterile scalpel and forceps, 
the film was positioned over the slide so that all the tissue section was covered, and the film 
was cut to fit the slide, leaving a 2-3mm border to prevent the film catching on the LCM 
system.  After placing the slides in a prewarmed oven for 10 min at 60°C, they were taken 
 5 
 
out and pressure was applied using a roller to increase the film-section contact area. Slides 
were then placed back in the oven for a further 10 min. 
 
2.4 LCM cap preparation 
The film layer of a CapSure Macro LCM cap (Life technologies or Applied 
Biosystems Arcturus Engineering, Mountain View, CA, USA) was peeled off using sterile 
forceps and discarded, and the cap placed back into the tray. Although the cells are not 
collected onto the LCM cap, it is still needed to focus the laser when carrying out the xMD 
process. 
 
2.5 Expression Microdissection 
Expression microdissection was performed using a Veritas LCM system (Applied 
Biosystems). The following parameters were used: 50µm spot size, 50ms laser pulse 
duration and 70mW laser power, set to continuously fire.  
 
2.6 RNA extraction 
After microdissection, a sterile scalpel was used to cut the film surrounding the target 
area and carefully removed from the slide before being placed in a sterile 0.2ml Eppendorf 
tube.  Total RNA was extracted from microdissected cells using a modified protocol that 
utilised the Recoverall Total Nucleic Acid Kit for FFPE (Life Technologies, CA, USA) and 
RNAqueous Micro kit (Life Technologies, CA, USA). Approximately 200 cells were collected. 
RNA extraction was conducted with the following protocol. Protease digestion, and nucleic 
DFLGLVRODWLRQZHUHFDUULHGRXWDVLQWKHPDQXIDFWXUHU¶VSURWRFROIRU5HFRYHUDOO7RWDO1XFOHLF
Acid Kit for FFPE kit (step C1 through to step D2). Briefly, 100µl digestion buffer and 4µl 
protease was added to the Eppendorf containing the film. Samples were then mixed by 
swirling followed by incubation at 50°C for 15 mins, then 80°C for 15 mins. 120µl isolation 
additive and 275µl 100% ethanol were then added to the mixture and mixed by pipetting. 
Samples were then transferred to cartridge filters included in the RNAqueous Micro kit for 
ZDVKVWHSVHOXWLRQDQG'1DVHWUHDWPHQWFDUULHGRXWDVLQWKHPDQXIDFWXUHU¶VSURWRFROVWHS
B5 through to step C4). All the sample was loaded onto the cartridge assembly and 
centrifuged for 1 min at 10,000xg. 180µl wash buffer 1 was added to the cartridge assembly 
and centrifuged for 1 min at 10,000xg. This was followed by two washes with wash buffer 
2/3, each of which was centrifuged for 30s at 10,000xg. The cartridge assembly was then 
centrifuged for 1 min at 10,000xg to remove any residual fluid. 10µl elution solution, 
preheated to 95°C was added to the cartridge assembly and incubated for 5 mins at RT, 
followed by centrifugation for 1 min at 10,000xg. This step was repeated to produce a final 
total elution volume of 20µl. The sample then underwent DNase treatment. 2µl 10x DNase I 
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buffer and 1µl DNase I was added and mixed by gentle pipetting. Samples were then 
incubated for 20 mins at 37°C. 2µl DNase inactivation reagent was added and incubated for 
2 mins at RT. Samples were then centrifuged for 90s at 16,000xg.  
A NanoDrop 1000 spectrophotometer (Thermoscientific, UK) was used to determine 
the quantity of the RNA and 2100 Bioanalyzer, RNA 6000 Pico LabChip (Agilent, Palo Alto, 
CA, USA) was used to determine RNA quality.  
 
2.7 Reverse transcriptase polymerase chain reaction (RT-PCR) 
Reverse transcriptase polymerase chain reaction (RT-PCR) is a standard and 
reliable method of assessing the cell phenotype specific genes from the RNA extracted from 
LCM isolated cells [14], as well as xMD isolated cells [6], making this a viable method of 
validating the isolation of an enriched, specific cell population, as well as indicating 
contamination levels of non-specific cells.  
cDNA was synthesised using the Superscript III reverse transcriptase kit (Life 
TechnologieV&$86$ZLWKUDQGRPSULPHUVDVGHVFULEHGLQWKHPDQXIDFWXUHU¶VSURWRFRO
Gene-specific PCR primers were either designed in house or obtained from commercially 
available sources.  PCR was performed using 50ng cDNA, 2x ReddyMix PCR master-mix 
(Thermoscientific, UK) with optimised concentrations of forward and reverse primers (Table 
1), in a total volume of 20µl. A denaturation step at 95°C for 10 min was followed by 
amplification of the products: 30 cycles at 95°C for 15s, 60°C for 60s, then 72°C for 15 min. 
PCR products were visualised on a 3% agarose gel stained with ethidium bromide. 
 
Table 1. Primer sequence   
Gene  Primer Sequence Product Size 
GFAPGfap F: CTG ATT CAG CCC AGA GGG TTA 
R: TGA AGA GCA GGG AGC ATA AAG C 
82bp 
CD68Cd68 F: CAC AGT GGA CAT TCT CAG CG 
R: AGA GCA GGT CCA GGT GAA TTG 
123bp 
OLIG2Olig2 F: ACC TGG GGG CTT GAC AAA AG 
R: GCA TCG CGA TTT CGT TGA T 
136bp 
TUB3Tub3 F:GGA GGA GGG GGA GAT GTA TGA A 
R:CCA GCT GCG AGC AAC TTC AC 
77bp 
Key: F, Forward; R, Reverse 
 
3. Results  
3.1 Expression microdissection enables the enriched isolation of specific cell-types from 
FFPE tissue 
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Standard immunohistochemistry enabled the identification of the target cell type. 
NeuN+ neurones displayed large round immunopositive nuclei, while GFAP+ astrocytes 
displayed stellate morphology with processes extending out of the cell body (Figure 2C). 
NeuN+ neurones and GFAP+ astrocytes were isolated using expression microdissection on 
a Veritas laser-capture microdissection system. The laser irradiated the entire tissue, only 
activating the EVA polymer film over the immunopositive cells that bound the DAB 
chromaogen, due to the transient increase in temperature, fusing the film with the underlying 
cells. When the film was lifted off, the unwanted (unlabelled) cells were left behind (Figure 
2B & 3D).  
 
 
3.2 RNA quality 
Following RNA isolation from the xMD isolated specific immunoreactive cells, the RIN 
value was assessed (Figure 43). In the representative examples shown, before xMD the RIN 
value was 3.0, and after xMD the RIN value decreased by 0.3to 2.4. 
 
3.3 PCR of cell phenotype specific transcripts confirms enrichment of specific cell 
populations using xMD  
Expression microdissection is suitable for the procurement and isolation of neurones 
and astrocytes, resulting in enriched target cell samples. RNA isolated from NeuN+ cells had 
high levels of Tubulin 3 transcripts with no transcripts for GfapGFAP, CD68 Cd68 or 
OLIG2Olig2, confirming that extracted RNA represents a highly-enriched neuronal 
population (Figure 5). This was also true for GFAP+ cells, which had high levels of GFAP 
Gfap transcripts with lower levels of Tubulin 3 and no detectable CD68 Cd68 and OLIG2 
Olig2 transcripts (Figure 5).  
  
4. Discussion 
The isolation of enriched cell populations from post-mortem material is key to 
identifying the role(s) these cells play in neurological diseases.  To date, the majority of 
studies have examined disease-associated changes in gene expression in whole tissue 
extracts, which likely mask the specific contribution of individual cell populations [2, 5, 16]. In 
the current study we demonstrate that enriched cell populations can be successfully isolated 
from CNS tissue by xMD. Whilst not being entirely homogeneous, the extract achieved using 
this approach is highly enriched for the cell type of interest, as confirmed by RT-PCR. While 
isolated neurones had no detectable levels of glial transcripts, low levels of neuronal 
transcripts were present in the xMD-LVRODWHGDVWURF\WHVOLNHO\UHIOHFWLQJWKHWDUJHWFHOOV¶
proximity to axons.  Therefore, xMD is suitable for the procurement and isolation of neurones 
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and astrocytes from post-mortem FFPE tissue, resulting in enriched target cell samples.  In 
addition to demonstrating the high recovery rate of the specific cell of interest, we also show 
that the RNA integrity of the xMD isolated cells is suitable for further downstream analysis, 
confirming previous xMD studies [4, 6]. 
FFPE CNS tissue blocks are widely used to immunohistochemically characterise the 
detailed cellular pathology associated with specific neurological diseases.  Whilst classical 
neuropathology is a key element of many studies, we demonstrate that the quantity and 
quality of RNA collected from FFPE tissue utilising the xMD method is of sufficient quality to 
carry out further molecular analyses.  We demonstrate cellular isolation from cortical regions, 
but it should be noted that other studies have used different tissues with higher cellular 
densities to obtain cells via xMD [7, 12].  While it is inevitable that some RNA will be 
degraded during the fixation and processing of the tissue, we demonstrate that the RIN 
value of the isolated cells is comparable with cells isolated from frozen CNS tissue [15]. In 
theory, this method could also be applied to frozen tissue; however, a modified rapid 
immunostaining protocol, as previously described [15], is advised.   Previous studies have 
also shown that samples with a wide range of RIN values (RIN 1-8.5) can be used in gene 
expression studies with successful outcomes [10, 13]. 
In the current study we demonstrate that xMD is a robust approach for isolating an 
enriched population of specific CNS cell types, and suggest that with optimisation, this 
method could be extended and further applied to the isolation of any desired cell type 
provided a suitable cell-specific antibody is available to allow binding of a chromoagen in 
order for the xMD process to be carried out. Whilst we performed this study on rat tissue, it 
could in theory, be used to isolate other CNS specific cell types from other species, including 
human and mouse. Human tissue has been shown to be suitable for use in conjunction with 
xMD [4, 6].  
xMD, whilst still in its infancy, addresses many of the limitations associated with basic 
LCM techniques, such as the need for operator-based identification of the cell of interest 
based on morphology, which can result in the non-specific cell contamination of the enriched 
cell sample. The current study outlines the detailed methodology of how different CNS cell 
types can be microdissected without the need for visualisation by an operator, thereby 
reducing the chance of a cell being wrongly identified. It also prevents the isolation of a cell 
with similar morphology to the cell type of interest from being mistakenly picked, as only cells 
that are immunopositive adhere to the film when the tissue is irradiated. xMD also negates 
the need for a microscope or visualisation of the cell of interest, making the process 
operator-independent.  
A further advantage of the xMD technique is its potential to address the low recovery 
rate associated with basic LCM, as larger numbers of the cell of interest are likely to adhere 
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to the EVA polymer film than can be identified by the operator using LCM. LCM is also a 
highly time consuming process and this too is addressed by xMD, as the laser can be set to 
continuously fire without an operator being present during this process. Therefore, xMD can 
be employed to rapidly isolate enriched cell-specific populations from post-mortem material. 
Further developments into xMD are still occurring [7].  These include the 
development of a handheld device that would further streamline the process, making it less 
time consuming for the operator due to the laser only having to fire over the tissue a few 
times in quick succession, meaning that this process in theory make take just a few minutes. 
A handheld device would also make it more accessible to laboratories where LCM 
equipment is not readily available. 
 
5. Conclusion 
To summarise, this paper documents a detailed methodological approach for the 
isolation of specific cell types from FFPE tissue utilising expression microdissection as the 
method of isolation, whilst also addressing and overcoming the pitfalls of LCM to acquire 
enriched CNS cell populations. Whilst the use of FFPE tissue does have its limitations, it is 
an extremely valuable resource that is widely available and easy to store, making the RNA 
obtained from xMD-isolated specific, enriched cell populations from FFPE material  a viable 
option for studying changes in the gene expression profile associated with the pathogenesis 
of a range of neurological diseases.  
While xMD has some limitations, this technique allows enriched cell populations to be 
isolated from FFPE tissue, thereby enabling the role of these cells in neurological disease to 
be investigated. Utilising this approach, specifically by applying it to well characterised 
human tissue, would enable underlying pathogenic mechanisms to be elucidated and to 
identify potential targets for developing novel treatment strategies. In this respect, xMD is 
more relevant than other useful, but less reflective, approaches to understanding 
neurodegenerative disease, such as the use of cell lines and animal models [9]. 
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Figure legends: 
Figure 1. Schematic representation of xMD. Immunopositive cells with the bound DAB 
chromogen are covered with a clear EVA polymer. The entire tissue is then irradiated with 
the IR laser of a LCM system. The EVA polymer melts at the site of the immunopositive cell 
due to the increased temperature caused by the chromagen DAB. This then bonds the EVA 
polymer film to the target cells. 
Figure 2. Immunohistochemical identification of astrocytes and neurones. (A) Glial fibrillary 
acidic protein (GFAP) was used to identify astrocytes and (B) NeuN was used to identify 
neurons. Scale bar represents 50µm. 
Figure 3. Expression microdissection of (A,B) NeuN+ neurones and (C,D) GFAP+ astrocytes 
from FFPE post-mortem rat brain tissue. Immunopositive cells were isolated using 
expression microdissection on a Veritas laser-capture microdissection system. The laser 
irradiated the entire tissue, only activating the EVA polymer film on the immunopositive cells 
bound the DAB chromogen, due to the transient increase in temperature. The film fused with 
the underlying cells. The film was lifted off, leaving unwanted cells behind (B,D). The isolated 
cells were attached to the film, to then undergo RNA extraction. 
Figure 4. Representative RNA integrity number (RIN) of samples before and after xMD. (A) 
Before (RIN 3.0) and (B) after (RIN 2.7) xMD isolation of NeuN+ neurones. (C) Before (RIN 
2.7) and (D) after (RIN 2.4) xMD isolation of GFAP+ astrocytes. 
Figure 5. RT-PCR of transcripts in cells isolated by expression microdissection. NeuN+ 
neurones are associated with high levels of Tubulin 3 transcripts (77bp). GFAP+ astrocytes 
are associated with high levels of Gfap transcripts (82bp).  CD68 (123bp), Olig2 (136bp).  
NTC: no template control; positive control: whole tissue extract. 
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